News
Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections, and, in ...
The only available treatment for a patient with coeliac disease is a strict gluten-free diet, which is often not enough on ...
Drug discovery, and science in general, are fields built on data. Foundation models bring new capabilities by integrating ...
Molbreevi – a new inhaled formulation of the well-established and off-patent white blood cell stimulator molgramostim – is ...
Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...
In another signal of downgraded support for COVID-19 vaccination programmes under the Trump administration, the CDC has ...
Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could ...
The Trump administration has intervened in a long-running lawsuit over the abortion pill mifepristone, asking a federal court judge to dismiss a lawsuit that could have restricted access to the drug.
The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...
The results show an impressive 63% objective response rate (ORR) in 43 evaluable patients in a phase 2 trial, as of a 27th ...
Beghou Consulting hires new CEO, AI expert. Beghou Consulting, an Evanston, Illinois-based consultancy firm supporting life ...
The field of 3D bioprinting technology is witnessing rapid advancements, offering new possibilities in regenerative medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results